DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 144 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,830,327 | -26.9% | 233,699 | -17.5% | 0.02% | -25.0% |
| Q3 2022 | $5,242,000 | +11.9% | 283,348 | -20.4% | 0.03% | +16.7% |
| Q2 2022 | $4,683,000 | -18.1% | 356,138 | -42.3% | 0.02% | -25.0% |
| Q1 2022 | $5,718,000 | +31.9% | 616,873 | +39.0% | 0.03% | +33.3% |
| Q4 2021 | $4,336,000 | +115.9% | 443,762 | +1275.5% | 0.02% | -38.5% |
| Q4 2019 | $2,008,000 | +106.4% | 32,263 | +12.6% | 0.04% | +129.4% |
| Q3 2019 | $973,000 | – | 28,654 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $18,687,872 | 15.44% |
| Redmile Group, LLC | 5,582,105 | $86,243,522 | 3.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,218,638 | $80,627,957 | 1.80% |
| BRAIDWELL LP | 3,241,351 | $50,078,873 | 1.65% |
| Parkman Healthcare Partners LLC | 491,772 | $7,597,877 | 1.65% |
| Sunesis Advisors, LLC | 96,299 | $1,487,820 | 1.07% |
| ARMISTICE CAPITAL, LLC | 4,100,000 | $63,345,000 | 0.91% |
| Deep Track Capital, LP | 1,363,201 | $21,061,455 | 0.86% |
| AlphaCentric Advisors LLC | 72,500 | $1,120,125 | 0.77% |
| Ikarian Capital, LLC | 174,510 | $2,696,179 | 0.61% |